Morse-clustering of a Topological Data Analysis Network Identifies Phenotypes of Asthma Based on Blood Gene Expression Profiles

Stratified medicine requires discretisation of disease populations for targeted treatments. We have developed and applied a discrete Morse theory clustering algorithm to a Topological Data Analysis (TDA) network model of 498 gene expression profiles of peripheral blood from asthma and healthy participants. The Morse clustering algorithm defined nine clusters, BC1-9, representing molecular phenotypes with discrete phenotypes including Type-1, 2 & 17 cytokine inflammatory pathways. The TDA network model and clusters were also characterised by activity of glucocorticoid receptor signalling associated with different expression profiles of glucocorticoid receptor (GR), according to microarray probesets targeted to the start or end of the GR mRNA’s 3’ UTR; suggesting differential GR mRNA processing as a possible driver of asthma phenotypes including steroid insensitivity.

[1]  S. Walker,et al.  Anti-IgE for chronic asthma in adults and children. , 2006, The Cochrane database of systematic reviews.

[2]  Borislav D. Dimitrov,et al.  Innate and adaptive T cells in asthmatic patients: Relationship to severity and disease mechanisms , 2015, The Journal of allergy and clinical immunology.

[3]  P. Y. Lum,et al.  Extracting insights from the shape of complex data using topology , 2013, Scientific Reports.

[4]  C. Auffray,et al.  Longitudinally Stable, Clinically Defined Clusters of Patients with Asthma Independently Identified in the ADEPT and U-BIOPRED Asthma Studies. , 2016, Annals of the American Thoracic Society.

[5]  C. Auffray,et al.  Severe asthma exists despite suppressed tissue inflammation: findings of the U-BIOPRED study , 2016, European Respiratory Journal.

[6]  Erik J. Saude,et al.  Metabolomic biomarkers in a model of asthma exacerbation: urine nuclear magnetic resonance. , 2009, American journal of respiratory and critical care medicine.

[7]  G. Carlsson,et al.  Topology based data analysis identifies a subgroup of breast cancers with a unique mutational profile and excellent survival , 2011, Proceedings of the National Academy of Sciences.

[8]  Charles Auffray,et al.  Application of ’omics technologies to biomarker discovery in inflammatory lung diseases , 2013, European Respiratory Journal.

[9]  Daniel J. Devine,et al.  Cytoplasmic translocation of p21 mediates NUPR1‐induced chemoresistance , 2012, FEBS letters.

[10]  C. Auffray,et al.  A Severe Asthma Disease Signature from Gene Expression Profiling of Peripheral Blood from U‐BIOPRED Cohorts , 2017, American journal of respiratory and critical care medicine.

[11]  B. Kang,et al.  Regulation of Serotonin-Induced Trafficking and Migration of Eosinophils , 2013, PloS one.

[12]  John F Alcorn,et al.  A tale of two cytokines: IL-17 and IL-22 in asthma and infection , 2014, Expert review of respiratory medicine.

[13]  G. Mutlu,et al.  Regulation of allergic lung inflammation by endothelial cell transglutaminase 2. , 2015, American journal of physiology. Lung cellular and molecular physiology.

[14]  D. Trump,et al.  Dexamethasone Enhances 1α,25-Dihydroxyvitamin D3 Effects by Increasing Vitamin D Receptor Transcription* , 2011, The Journal of Biological Chemistry.

[15]  Barmak Modrek,et al.  T-helper type 2-driven inflammation defines major subphenotypes of asthma. , 2009, American journal of respiratory and critical care medicine.

[16]  C. Powell,et al.  Anti-IL5 therapies for asthma. , 2017, The Cochrane database of systematic reviews.

[17]  Adam R Ferguson,et al.  Topological data analysis for discovery in preclinical spinal cord injury and traumatic brain injury , 2015, Nature Communications.

[18]  T. Laidlaw,et al.  PLA2G5 regulates transglutaminase activity of human IL‐4‐activated M2 macrophages through PGE2 generation , 2016, Journal of leukocyte biology.

[19]  Frédéric Baribaud,et al.  U‐BIOPRED clinical adult asthma clusters linked to a subset of sputum omics , 2017, The Journal of allergy and clinical immunology.

[20]  R. Reiter,et al.  Melatonin and Its Relation to the Immune System and Inflammation , 2000, Annals of the New York Academy of Sciences.

[21]  C. Auffray,et al.  A Transcriptome‐driven Analysis of Epithelial Brushings and Bronchial Biopsies to Define Asthma Phenotypes in U‐BIOPRED , 2017, American journal of respiratory and critical care medicine.

[22]  J. Cidlowski,et al.  AUUUA motifs in the 3′UTR of human glucocorticoid receptor α and β mRNA destabilize mRNA and decrease receptor protein expression , 2002, Steroids.

[23]  H. Bisgaard,et al.  The burden of severe asthma in childhood and adolescence: results from the paediatric U-BIOPRED cohorts , 2015, European Respiratory Journal.

[24]  K. Chung,et al.  p38 mitogen-activated protein kinase pathways in asthma and COPD. , 2011, Chest.

[25]  D. Kamp,et al.  Circulating microRNA Signatures Associated with Childhood Asthma. , 2015, Clinical laboratory.

[26]  V. Quesada,et al.  Cystatin D is a candidate tumor suppressor gene induced by vitamin D in human colon cancer cells. , 2009, The Journal of clinical investigation.

[27]  Ioannis Pandis,et al.  Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort , 2015, European Respiratory Journal.

[28]  Libing Song,et al.  miR-486 sustains NF-κB activity by disrupting multiple NF-κB-negative feedback loops , 2012, Cell Research.

[29]  I. Pavord,et al.  Association between neutrophilic airway inflammation and airflow limitation in adults with asthma. , 2007, Chest.

[30]  A. Prasse,et al.  A system biology study of BALF from patients affected by idiopathic pulmonary fibrosis (IPF) and healthy controls , 2014, Proteomics. Clinical applications.

[31]  G. Chrousos,et al.  Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. , 1995, The Journal of clinical investigation.